ESR1 and breast cancer: Evidence for this pathway first came from studies in the breast cancer cell line MCF-7, in which IMS stress induces estrogen receptor alpha (ERα) phosphorylation and activation in an ROS- and AKT-dependent manner, which in turn upregulates the IMS protease OMI (HTRA2) and NRF1.